Serum ferritin as a prognostic biomarker in CAR-T therapy for multiple myeloma: A meta-analysis. Biomol Biomed [Internet]. 2025 Mar. 28 [cited 2025 Nov. 3];25(11):2416–2427. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/12129